Creative Planning
ETON icon

Creative Planning’s Eton Pharmaceutcials ETON Stock Holding History

Creative Planning’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-85,300
Closed -$624K – 2229
2021
Q1 		$624K Buy
85,300
+39,565
+87% +$338K ﹤0.01% 1285
2020
Q4 		$372K Buy
45,735
+17,000
+59% +$131K ﹤0.01% 1482
2020
Q3 		$227K Buy
+28,735
New +$196K ﹤0.01% 1603

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Creative Planning's ETON Position: Q2 2021 in Review

Creative Planning sold out of Eton Pharmaceutcials (ETON) in Q2 2021, closing a stake of 85,300 shares — an estimated $624K sold.

Creative Planning first reported a position in ETON in Q3 2020 and held it in 3 quarters. The position peaked at $624K in Q1 2021. 46 funds tracked by Wall St. Rank hold ETON as of Q2 2021.

  • Creative Planning reported no remaining Eton Pharmaceutcials position as of Q2 2021 after selling out during the quarter.
  • Creative Planning sold 85,300 Eton Pharmaceutcials shares in Q2 2021, an estimated $624K.
  • Creative Planning first reported a position in Eton Pharmaceutcials in Q3 2020 and held it in 3 quarters.
  • Creative Planning's Eton Pharmaceutcials position peaked at $624K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.